✦ LIBER ✦

Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time

✍ Scribed by Stephen W Duffy, Dharmishta Parmar

Book ID: 120699095
Publisher: BioMed Central
Year: 2013
Tongue: English
Weight: 276 KB
Volume: 15
Category: Article
ISSN: 1465-5411
DOI: 10.1186/bcr3427

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Reply: Estimation of lead-time and overd

Reply: Estimation of lead-time and overdiagnosis in breast cancer screening

✍ Duffy, S W; Lynge, E; Jonsson, H 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 41 KB

Lead Time and Overdiagnosis in Prostate-

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

✍ Kibel, A.S. 📂 Article 📅 2010 🏛 Elsevier Science ⚖ 49 KB

Lead time and overdiagnosis in prostate-

Lead time and overdiagnosis in prostate-specific antigen screening: importance of methods and context

✍ Kibel, A.S. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 46 KB

Estimates of lead time and length bias i

Estimates of lead time and length bias in a breast cancer screening program

✍ Michael Shwartz 📂 Article 📅 1980 🏛 John Wiley and Sons 🌐 English ⚖ 831 KB

Assume that the benefit of screening for breast cancer with a combination of mammography and a clinical examination is measured by comparing the five-year survival rate of women detected by screening to the five-year survival rate of women who surface clinically with breast cancer, e.g., to the surv

Estimate of overdiagnosis of breast canc

Estimate of overdiagnosis of breast cancer due to mammography after adjustment for lead time. A service screening study in Italy

✍ Eugenio Paci, Guido Miccinesi, Donella Puliti, Paola Baldazzi… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 439 KB

Effects of lead time, length bias, and f

Effects of lead time, length bias, and false-negative assurance on screening for breast cancer

✍ Stephan Pelikan; Myron Moskowitz 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 626 KB